Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001680367-25-000017
Filing Date
2025-04-30
Accepted
2025-04-30 07:12:58
Documents
17
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A sttk-20241231.htm   iXBRL 10-K/A 357298
2 EX-31.1 sub-certxsection302xceo202.htm EX-31.1 5942
3 EX-31.2 sub-certxsection302xcfo202.htm EX-31.2 5982
  Complete submission text file 0001680367-25-000017.txt   886122

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20241231.xsd EX-101.SCH 2544
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20241231_lab.xml EX-101.LAB 139337
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20241231_pre.xml EX-101.PRE 75352
19 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20241231_htm.xml XML 8057
Mailing Address 500 W. 5TH STREET AUSTIN TX 78701
Business Address 500 W. 5TH STREET AUSTIN TX 78701 512-900-4690
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39593 | Film No.: 25890914
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)